Targeting chromatin remodeling complexes to inhibit oncogenic androgen receptor activity in prostate cancer

Ended Project Grant Awarded Last action

Award ID
W81XWH2110500
Recipient
Awarding agency
Obligated
$900,640

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Ann Arbor, MI 48109, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The University of Michigan was awarded a $900,640 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420).

The grant will fund research from September 2021 through August 2024 to target chromatin remodeling complexes in order to inhibit oncogenic androgen receptor activity in prostate cancer. Through basic, applied, and advanced biomedical research supported by this program, the University aims to transform health care for service members and the public by investigating medical solutions for the battlefield and developing innovative treatments. The funding will support the University's work investigating approaches to prostate cancer treatment by exploring epigenetic mechanisms of androgen receptor regulation.

Quick answers

Who received award W81XWH2110500?

W81XWH2110500 was awarded to Regents Of The University Of Michigan by Medical Command (Department of the Army) on September 29, 2021.

How much is award W81XWH2110500 worth?

$900,640 has been obligated on W81XWH2110500.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login